TCL Archive NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies November 6, 1987
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review. November 14, 2003
TCL Archive Cooperative Groups Get Reprieve From Cut As Budget Is Flatlined At Fiscal 2006 Level. June 8, 2007
